505 - 516 of 7279 results
0.75 CME CREDIT

Guidelines for immunizations and cancer screening recommendations are constantly in flux as new data emerges. This session will review some current recommendations for vaccinations and cancer screening in children and adults in addition to controversies related to these recommendations.


1 CME CREDIT

This talk will be aimed for primary care physicians with a goal of understanding and defining CKD as its prevalence continues to rise in the era of hypertension, diabetes and obesity epidemics. The attendant will understand and identify patients at risk and with CKD and the natural course of the disease. They will be supplied with tools clinically proven to slow down progression of the disease and understand the denouement of CKD.


1 CME CREDIT

This presentation will provide an updated on newer approaches to the management of lipid disorders for the primary and secondary prevention of atherosclerotic cardiovascular disease and hypertriglyceridemia-induced acute pancreatitis. It will also provide an evidence-based approach to the management of lipid disorders in special populations. The focus will be on the recommendations provided by the 2018 ACC/AHA Guidelines on the Treatment of Blood Cholesterol and the application of these clinical guidelines in patient care.


0.75 CME CREDIT

The faculty will discuss approaches to the diagnosis and treatment of hypothyroidism. The indications and targets for thyroid hormone replacement will be reviewed, including those for subclinical hypothyroidism. There are special conditions influencing selection of thyroid preparation and adjustment of dose that will be discussed: thyroid cancer, persistent hypothyroid symptoms, cardiac disease, and interfering drugs. The systematic approach to the evaluation of hyperthyroidism will feature the appropriate selection of tests and imaging studies, and application of new guidelines. Participants will learn about the treatment of hyperthyroidism with anti-thyroid drugs and receive guidance on selection of drug and assessing response to therapy. New guidelines on the treatment of thyroid disease associated with infertility and pregnancy will be described.


1 CME CREDIT

The epidemiology of acute coronary syndromes has changed dramatically in the past few decades, with lower overall incidence of myocardial infarction (MI) -- particularly ST elevation MI -- and improved survival after an incident MI. The diagnosis and classification of MI is challenging, particularly in the era of sensitive troponin assays. Clinicians must be aware of the frequent occurrence and causes of troponin elevations from conditions other than MI. Following diagnosis, risk stratification for patients with non-ST elevation ACS is critical to making prudent decisions and selecting among the multitude of different options for invasive and medical therapies. When considering potent antiplatelet and antithrombotic therapies, it is of paramount importance to also consider bleeding risk. Primary care clinicians play a critical role in determining the optimal duration of dual antiplatelet therapy, ensuring appropriate use and adherence to evidence-based medical therapies, and addressing lifestyle factors that can help prevent or modify the course after an ACS event.


1 CME CREDIT

By determining the target of inflammation in the joint and the distribution of affected joints, a clinician can distinguish among non-inflammatory arthritis (osteoarthritis), other non-inflammatory rheumatic conditions (like fibromyalgia), and inflammatory conditions such as inflammatory synovitis (rheumatoid arthritis) and inflammatory enthesitis (ankylosing spondylitis, psoriatic arthritis).


0.75 CME CREDIT

This talk will emphasize new guidelines for cardiovascular disease prevention, highlighting the big three risk factors: hypertension, hyperlipidemia, and diabetes. The talk will also discuss controversies and commonalities, and offer practical tips for implementing the guidelines.


1 CME CREDIT

This talk will review the impact of cannabis use and legalization of it in clinical practice.


1 CME CREDIT

Over 40% of men over the age of 50 will suffer from erectile dysfunction (ED) or hypogonadism and these conditions often co-exist in many men. Clinicians should be aware of the new 2018 American Urologic Association (AUA) ED guidelines and how the paradigm of ED treatments has now changed. In addition, over the past 5 years there have been numerous controversies with the diagnosis and management of hypogonadism. Clinicians should be aware of these controversies and should be familiar with the new 2018 AUA and Endocrine guideline on testosterone therapy.


0.75 CME CREDIT

This case-based talk will review common challenges and situations that both neurologists and primary care clinicians face in caring for patients with movement disorders. Movement disorders can be divided into hypokinetic (reduced and slowed movements) and hyperkinetic (excessive and quick movements), and the faculty will provide a framework to recognize them. Participants will learn about movement disorder assessment, treatment challenges, and explore new options in both essential tremor and in Parkinson’s disease. Lastly, the faculty will contextualize Parkinson’s disease, along with Lewy Body Dementia, in the spectrum of neurodegenerative conditions.


0.75 CME CREDIT

The session will review the latest clinical information regarding cannabis use for medical purposes. Particular attention will be given to the latest information regarding treating inflammatory bowel diseases and neurologic disorders. Pulmonary and cardiovascular risks will be reviewed. The speaker will also discuss marijuana use for the elderly and inform participants about issues related to impaired driving.


1 CME CREDIT

Join this talk for an enlightening look at health system waste and failures. Dr. Nash will provide an essential road map connecting high-value care to population health. With this model, participants will be equipped to evaluate and improve the future of patient engagement.This presentation will (1) provide an update on criteria to diagnose osteoporosis and identification of persons at high risk of fracture; (2) review treatment guidelines; and (3) discuss new concepts regarding treatment, such as drug selection, duration of treatment, drug holidays, and standard treatment approach vs. goal-directed treatment.